BD to Announce Financial Results for its Second Quarter of Fiscal 2025
BD (NYSE: BDX), a leading global medical technology company, has scheduled a financial results announcement for its second quarter of fiscal year 2025. The company will host an audio webcast on May 1, 2025, at 8 a.m. ET to discuss the quarterly performance ended March 31, 2025.
The presentation will include summary financial information, operational updates, and strategic insights. Investors can access the webcast through BD's investor relations website, where a replay will be available afterward. Prior to the call, BD will release detailed financial information and presentation materials on their investor website.
BD (NYSE: BDX), un'azienda leader nella tecnologia medica a livello globale, ha programmato un annuncio dei risultati finanziari per il secondo trimestre dell'anno fiscale 2025. L'azienda ospiterà un webcast audio il 1 maggio 2025, alle 8:00 ET per discutere le performance trimestrali terminate il 31 marzo 2025.
La presentazione includerà informazioni finanziarie riassuntive, aggiornamenti operativi e approfondimenti strategici. Gli investitori possono accedere al webcast tramite il sito web delle relazioni con gli investitori di BD, dove sarà disponibile una registrazione successivamente. Prima della chiamata, BD rilascerà informazioni finanziarie dettagliate e materiali di presentazione sul proprio sito per gli investitori.
BD (NYSE: BDX), una empresa líder en tecnología médica a nivel mundial, ha programado un anuncio de resultados financieros para su segundo trimestre del año fiscal 2025. La empresa llevará a cabo un webcast de audio el 1 de mayo de 2025, a las 8 a.m. ET para discutir el rendimiento trimestral que finalizó el 31 de marzo de 2025.
La presentación incluirá información financiera resumida, actualizaciones operativas y perspectivas estratégicas. Los inversores pueden acceder al webcast a través del sitio web de relaciones con inversores de BD, donde estará disponible una grabación posteriormente. Antes de la llamada, BD publicará información financiera detallada y materiales de presentación en su sitio web para inversores.
BD (NYSE: BDX), 세계적인 의료 기술 회사,는 2025 회계연도 2분기 재무 결과 발표를 예정하고 있습니다. 회사는 2025년 5월 1일 오전 8시 ET에 분기 실적에 대해 논의하기 위해 오디오 웹캐스트를 진행할 것입니다. 이는 2025년 3월 31일에 종료된 분기에 대한 것입니다.
발표에는 요약된 재무 정보, 운영 업데이트 및 전략적 통찰력이 포함될 것입니다. 투자자들은 BD의 투자자 관계 웹사이트를 통해 웹캐스트에 접근할 수 있으며, 이후 재생이 가능합니다. 전화 회의 전에 BD는 투자자 웹사이트에 자세한 재무 정보와 발표 자료를 게시할 것입니다.
BD (NYSE: BDX), une entreprise leader dans le domaine de la technologie médicale à l'échelle mondiale, a programmé une annonce des résultats financiers pour son deuxième trimestre de l'exercice 2025. L'entreprise organisera un webinaire audio le 1er mai 2025 à 8h00 ET pour discuter des performances trimestrielles se terminant le 31 mars 2025.
La présentation comprendra des informations financières résumées, des mises à jour opérationnelles et des perspectives stratégiques. Les investisseurs peuvent accéder au webinaire via le site web des relations investisseurs de BD, où un replay sera disponible par la suite. Avant l'appel, BD publiera des informations financières détaillées et des supports de présentation sur son site pour les investisseurs.
BD (NYSE: BDX), ein führendes globales Medizintechnikunternehmen, hat eine Bekanntgabe der finanziellen Ergebnisse für das zweite Quartal des Geschäftsjahres 2025 geplant. Das Unternehmen wird am 1. Mai 2025 um 8 Uhr ET ein Audio-Webcast veranstalten, um die Quartalsleistung zum 31. März 2025 zu besprechen.
Die Präsentation wird zusammenfassende Finanzinformationen, betriebliche Updates und strategische Einblicke enthalten. Investoren können über die Investor-Relations-Website von BD auf den Webcast zugreifen, wo eine Wiederholung später verfügbar sein wird. Vor dem Anruf wird BD detaillierte Finanzinformationen und Präsentationsmaterialien auf ihrer Investor-Website veröffentlichen.
- None.
- None.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Adam Reiffe |
VP, Public Relations | Sr. Director, Investor Relations |
858.617.2361 | 201.847.6927 |
View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-second-quarter-of-fiscal-2025-302420164.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
When will BD (BDX) release its Q2 2025 earnings?
How can investors access BD's (BDX) Q2 2025 earnings call?
What period does BD's (BDX) Q2 2025 earnings cover?
Will BD (BDX) provide presentation materials for Q2 2025 earnings?
